The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways
The trial, conducted across multiple international sites and involving 725 adults living with obesity or overweight but without type 2 diabetes, concluded in April 2026 after 76 weeks of treatment
Patients with a history of gout should discuss monitoring strategies with their GP
Thrainsdottir I, Malmberg K, Olsson A, Gutniak M, Ryden L: Initial experience with GLP-1 treatment on metabolic control and myocardial function in patients with type 2 diabetes mellitus and heart failure
Getting this step right protects both your results and the integrity of the compound, since sloppy handling degrades the peptide and wastes money
Even a nurse I spoke with mentioned he takes a nap after his due to dizziness and nausea